The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patient: a literature review
Imatinib and nilotinib are first-line treatments for chronic myeloid leukemia (CML) patients, which act specifically against target cells. However, these drugs may cause side effects, such as electrolyte disturbances. This literature review aimed to provide a comparison of the effects of imatinib a...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
PAGEPress Publications
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/4a95a91f1fce4f65843fdb59d347e853 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|